bisantrene has been researched along with Breast Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (90.91) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forastiere, AA; Hughes, AK; Perry, MC; Wood, WC | 1 |
| Safa, AR; Tseng, MT | 1 |
| Cowan, JD; Osborne, CK; Sandbach, J; Von Hoff, DD | 1 |
| Alberts, DS; Bowden, GT; Ludwig, CU; Roberts, RA | 1 |
| Barnes, BC; Blumenschein, GR; Bodey, GP; Schell, FC; Yap, BS; Yap, HY | 1 |
| Coltman, CA; Cowan, JD; Gumbart, C; Hutchins, LF; Martino, S; McClure, S; Neidhart, J; Osborne, CK; Stephens, RL; Vaughan, CB | 1 |
| Chang, MN; Ingle, JN; Long, HJ; Schutt, AJ | 1 |
| Blumenschein, GR; Buzdar, AU; Esparza, L; Holmes, FA; Hortobagyi, GN; Yap, HY | 1 |
| Constanzi, JJ; Cowan, JD; Neidhart, JA; Osborne, CK; Vaughn, CB; Von Hoff, DD | 1 |
| Cavalli, F; Clavel, M; Gerard, B; Rozencweig, M; ten Bokkel Huinink, W | 1 |
| Ettinger, DS; Falkson, G; Kaplan, BM; Muggia, FM; Pandya, KJ; Skeel, RT | 1 |
3 trial(s) available for bisantrene and Breast Neoplasms
| Article | Year |
|---|---|
Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Female; Humans; Middle Aged; Mitoxantrone | 1991 |
A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Blood Pressure; Breast Neoplasms; Drug Administration Schedule; Female; Heart; Humans; Middle Aged; Neoplasm Metastasis | 1986 |
A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).
Topics: Adult; Aged; Alopecia; Anthracenes; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Female; Heart Failure; Humans; Leukopenia; Menopause; Middle Aged; Mitoxantrone; Nausea; Random Allocation; Receptors, Estrogen; Vomiting | 1985 |
8 other study(ies) available for bisantrene and Breast Neoplasms
| Article | Year |
|---|---|
Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer. A cancer and leukemia group B study.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Female; Hematopoietic Stem Cells; Humans; Middle Aged; Neoplasm Metastasis | 1984 |
Light, fluorescent, and electron microscopic analysis of cultured breast tumor cells (T-47D) treated with 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride.
Topics: Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line; Cell Survival; Clone Cells; Female; Humans; Microscopy, Electron; Microscopy, Fluorescence | 1983 |
Bisantrene, an active drug in patients with advanced breast cancer.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Nausea; Phlebitis | 1984 |
Reduced bisantrene-induced cytotoxicity and protein-associated DNA strand breaks under hypoxic condition.
Topics: Animals; Anthracenes; Breast Neoplasms; Cell Line; Cell Survival; DNA; Drug Evaluation; Female; Humans; Leukemia L1210; Mice; Oxygen; Proteins | 1984 |
Bisantrene, an active new drug in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Metastasis | 1983 |
Evaluation of bisantrene administered by 72-hour infusion in women with metastatic breast cancer.
Topics: Adult; Aged; Anthracenes; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Metastasis | 1986 |
Phase II evaluation of bisantrene in metastatic breast cancer.
Topics: Anthracenes; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Neoplasm Metastasis; Phlebitis | 1985 |
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study.
Topics: Adult; Aged; Anthracenes; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Pilot Projects | 1985 |